4McCullough LD, Alkayed NJ, Traystman R J, et al. Postischemic estrogn reduces hypoperfusion and secondary is chemia after experi mental[J]. Stroke,2001,32:796.
5Louissant A.Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain[J].Neuron,2004,34:945 -960.
6Behl C, Skutella T, Lezoualch F, et al. Neuroproteetion against oxidative stress by estrogen: Structure-activity relationship [ J ]. Mol Pharmacol, 1997, 51 (4) :535 -541.
二级参考文献35
1[1]Stein DG, Hoffman SW. Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries.Pediatr Rehabil, 2003, 6: 13-22.
2[2]Roof RL, Hall ED. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma, 2000, 17: 367-388.
3[3]Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol, 1994, 9: 619-626.
4[4]Hurn PD, Littleton-Kearney MT, Kirsch JR, et al. Postischemic cerebral blood flow recovery in the female: effect of 17 beta-estradiol. J Cere Blood Flow, 1995, 15:666-672.
5[5]Barbacanne MA, Rami J, Michal JB, et al. Estradiol increases rat aorta endothelium-derived relaxing factor activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production. Cardiovasc Res, 1999, 41:672-681.
6[6]Santizo R, Pelligrino DA. Estrogen reduces leukocyte adhesion in the cerebral circulation of female rats. J Cereb Blood Metab, 1999, 19: 1061-1065.
7[7]Green PS, Simpkins JW. Neuroprotective effects of estro-gens: potential mechanisms of action. Int J Dev Neurosci,2000, 18: 347-358.
8[8]Regan RF, Guo Y. Estrogens attenuate neuronal injurydue to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures. Brain Res, 1997,764: 133-140.
9[9]Moosmann B, Behl C. The antioxidant neuroprotectiveeffects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci US A, 1999, 96: 8867-8872.
10[10]Weaver CE, Park-Chung M, Gibbs TT, et al. 17beta-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res, 1997,761: 338-341.
3Fitzgerald R, Pirmohamed M. Aspirin resistance: effect of clinical, biochemical and genetic factors [ J ]. Phar- macol Ther,2011,130(2) :213 -225.
4Patrono C, Rocca B. Aspirin: promise and resistance in the new millennium [ J ]. Arterioscler Thromb Vasc Bi- ol,2008, 28(3) : s25 - s32.
5Schwartz KA, Schwartz DE, Barber K, et al. Non - compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients [ J ]. J Transl Med, 2008,6:46.
6Kasotakis G, Pipinos II, Lynch TG. Current evidence and clinical implications of aspirin resistance [ J ]. J Vasc Surg,2009, 50(6) : 1500 - 1510.
7Cuisset T, Frere C, Quilici J, et al. Aspirin noncompli- ance is the major cause of "aspirin resistance" in pa- tients undergoing coronary stenting [ J ]. Am Heart J, 2009, 157(5):889 -893.
8Spektor G, Fuster V. Drug insight- cyclo - oxygenase 2 inhibitors and cardiovascular risk - where are we now? [ J ]. Nat Clin Pract Cardiovasc Med, 2005,2 (6) : 290 - 300.
9Kour D, Tandon VR, Kapoor B, et al. Aspirin Resist- ance [J]. JK Science,2006,8(2) :116 - 117.
10Bauriedel G, Skowasch D, Schneider M, et al. Anti- platelet effects of angiotensin - converting enzyme in- hibitors compared with aspirin and clopidogrel: a pilot study with whole - blood aggregometry [ J ]. Am Heart J,2003, 145(2) :343 -348.
